Amur Minerals Corporation (CRTX) - Net Assets
Based on the latest financial reports, Amur Minerals Corporation (CRTX) has net assets worth GBX1.80 Million GBX (≈ $218.77 USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX2.38 Million ≈ $289.75 USD) and total liabilities (GBX583.34K ≈ $70.98 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CRTX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX1.80 Million |
| % of Total Assets | 75.5% |
| Annual Growth Rate | -30.0% |
| 5-Year Change | -93.57% |
| 10-Year Change | N/A |
| Growth Volatility | 32.94 |
Amur Minerals Corporation - Net Assets Trend (2016–2024)
This chart illustrates how Amur Minerals Corporation's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Amur Minerals Corporation for the complete picture of this company's asset base.
Annual Net Assets for Amur Minerals Corporation (2016–2024)
The table below shows the annual net assets of Amur Minerals Corporation from 2016 to 2024. For live valuation and market cap data, see Amur Minerals Corporation (CRTX) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX1.48 Million ≈ $179.46 |
-64.23% |
| 2023-12-31 | GBX4.12 Million ≈ $501.77 |
-82.17% |
| 2022-12-31 | GBX23.13 Million ≈ $2.81K |
+4.03% |
| 2021-12-31 | GBX22.23 Million ≈ $2.70K |
-3.07% |
| 2020-12-31 | GBX22.93 Million ≈ $2.79K |
+11.96% |
| 2019-12-31 | GBX20.48 Million ≈ $2.49K |
-12.80% |
| 2018-12-31 | GBX23.49 Million ≈ $2.86K |
-16.71% |
| 2017-12-31 | GBX28.20 Million ≈ $3.43K |
+10.28% |
| 2016-12-31 | GBX25.58 Million ≈ $3.11K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Amur Minerals Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2918155600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX66.22 Million | 4489.83% |
| Total Equity | GBX1.48 Million | 100.00% |
Amur Minerals Corporation Competitors by Market Cap
The table below lists competitors of Amur Minerals Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Contango Holdings PLC
LSE:CGO
|
$80.70K |
|
Bradda Head Holdings Ltd
LSE:BHL
|
$80.79K |
|
Mothercare PLC
LSE:MTC
|
$81.62K |
|
Twenty One Capital, Inc.
NYSE:XXI
|
$82.20K |
|
Adomos SA
PA:ALADO
|
$80.25K |
|
Boostheat
PA:ALBOO
|
$79.79K |
|
The Investment Company plc
LSE:INV
|
$79.35K |
|
SPECTRA7 MICROSYSTEMS
F:7M0A
|
$79.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amur Minerals Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,124,000 to 1,475,000, a change of -2,649,000 (-64.2%).
- Net loss of 607,000 reduced equity.
- Dividend payments of 47,000 reduced retained earnings.
- Other factors decreased equity by 1,995,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-607.00K | -41.15% |
| Dividends Paid | GBX47.00K | -3.19% |
| Other Changes | GBX-2.00 Million | -135.25% |
| Total Change | GBX- | -64.23% |
Book Value vs Market Value Analysis
This analysis compares Amur Minerals Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 52.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.71x to 52.52x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | GBX7.47 | GBX12.75 | x |
| 2017-12-31 | GBX7.36 | GBX12.75 | x |
| 2018-12-31 | GBX5.72 | GBX12.75 | x |
| 2019-12-31 | GBX4.45 | GBX12.75 | x |
| 2020-12-31 | GBX4.68 | GBX12.75 | x |
| 2021-12-31 | GBX3.49 | GBX12.75 | x |
| 2022-12-31 | GBX2.66 | GBX12.75 | x |
| 2023-12-31 | GBX0.47 | GBX12.75 | x |
| 2024-12-31 | GBX0.24 | GBX12.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amur Minerals Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -41.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2428.00%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.23x
- Recent ROE (-41.15%) is below the historical average (-38.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -20.52% | 0.00% | 0.00x | 1.15x | GBX-7.81 Million |
| 2017 | -4.27% | 0.00% | 0.00x | 1.03x | GBX-4.03 Million |
| 2018 | -13.38% | 0.00% | 0.00x | 1.12x | GBX-5.49 Million |
| 2019 | -8.91% | 0.00% | 0.00x | 1.04x | GBX-3.87 Million |
| 2020 | -6.64% | 0.00% | 0.00x | 0.76x | GBX-5.22 Million |
| 2021 | -5.12% | 0.00% | 0.00x | 0.77x | GBX-4.55 Million |
| 2022 | -10.58% | 0.00% | 0.00x | 1.03x | GBX-4.76 Million |
| 2023 | -233.92% | -16816.58% | 0.01x | 1.16x | GBX-10.06 Million |
| 2024 | -41.15% | -2428.00% | 0.01x | 1.23x | GBX-754.50K |
Industry Comparison
This section compares Amur Minerals Corporation's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $7,573,651
- Average return on equity (ROE) among peers: -278.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amur Minerals Corporation (CRTX) | GBX1.80 Million | -20.52% | 0.32x | $80.26K |
| 4BASEBIO UK SOCIETAS (4BB) | $7.12 Million | -72.33% | 0.64x | $951.45K |
| Aptamer Group PLC (APTA) | $245.81K | -274.50% | 4.65x | $205.09K |
| Arecor Therapeutics PLC (AREC) | $5.35 Million | -191.36% | 0.63x | $303.20K |
| Avacta Group PLC (AVCT) | $29.89 Million | -21.30% | 0.06x | $3.99 Million |
| BSF Enterprise Plc (BSFA) | $3.58 Million | -25.96% | 0.13x | $27.33K |
| Bioventix (BVXP) | $11.01 Million | 51.43% | 0.08x | $1.10 Million |
| Cizzle Biotechnology Holdings PLC (CIZ) | $32.00K | -956.25% | 1.81x | $127.81K |
| Fusion Antibodies PLC (FAB) | $50.13K | -935.06% | 5.06x | $193.60K |
| Faron Pharmaceuticals Oy (FARN) | $10.88 Million | -85.40% | 0.59x | $575.13K |
About Amur Minerals Corporation
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The c… Read more